4//SEC Filing
Kenny Kevin J. 4
Accession 0001209191-23-023453
CIK 0000884624other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 6:38 PM ET
Size
11.8 KB
Accession
0001209191-23-023453
Insider Transaction Report
Form 4
Kenny Kevin J
President of Global Spine
Transactions
- Award
Common Stock
2023-04-04+7,449→ 148,724 total - Award
Performance Share Units
2023-04-04+5,959→ 5,959 totalExercise: $0.00→ Common Stock (5,959 underlying) - Tax Payment
Common Stock
2023-04-03$16.75/sh−1,956$32,763→ 141,275 total - Award
Employee Stock Option (Right to Buy)
2023-04-04+17,061→ 17,061 totalExercise: $16.78Exp: 2033-04-04→ Common Stock (17,061 underlying)
Footnotes (3)
- [F1]Includes 121,401 previously reported unvested restricted stock units.
- [F2]Represents performance-based vesting restricted stock units ("PSUs") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achievement of an operating expense synergy target (on an annualized basis) for calendar year 2023 (the "Synergy Target"). The amount in the table above represents the target number of PSUs granted. The Synergy Target vesting percentage can be achieved at 100% (if 100% or more of the Synergy Target is achieved), 80% (if 80% but less than 100% of the Synergy Target is achieved), or 0% (if less than 80% of the Synergy Target is achieved).
- [F3]The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.
Documents
Issuer
Orthofix Medical Inc.
CIK 0000884624
Entity typeother
Related Parties
1- filerCIK 0001520400
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 6:38 PM ET
- Size
- 11.8 KB